Unified Parkinson's Disease Rating Scale


Also found in: Acronyms, Wikipedia.

Unified Parkinson's Disease Rating Scale

Neurology A measure of severity of Parkinson's disease, based on a scale from 0 to 160 total scale and 0 to 44 motor section. See Parkinson's disease.
References in periodicals archive ?
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results.
FOGQ = Freezing of Gait Questionnaire, MMSE = Mini-Mental Status Examination, UPDRS = Unified Parkinson's Disease Rating Scale.
Motoric tolerability was a key secondary endpoint in the study and was measured using Parts II and III of the Unified Parkinson's Disease Rating Scale, or UPDRS.
Unified Parkinson's Disease Rating Scale as Predictor of Peak Aerobic Capacity
Fahn S, Elton RL, members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale.
1) Unified Parkinson's Disease Rating Scale part III (UPDRS III)(2) Assessed with Unified Parkinson's Disease Rating Scale part II (UPDRS II)(3) Quality of life assessed with the Parkinson's Disease Questionnaire (PDQ-39)
The severity of patients' disability was assessed using the modified Hoehn and Yahr scale (15) and scores on the motor section (part III) of the Unified Parkinson's Disease Rating Scale (UPDRS).
The brain autopsies used for this study were from deceased participants from the Religious Order Study, a longitudinal clinical-pathological study of aging in community-dwelling nuns and priests who had no known dementia at enrollment, and who were evaluated for parkinsonian signs with the 26-item modified version of the motor portion of the Unified Parkinson's Disease Rating Scale prior to death.
The following data were recorded: (1) anthropometric variables, (2) the Unified Parkinson's Disease Rating Scale (UPDRS) [9], (3) Hoehn and Yahr (HY) scale [10], (4) the Activities-specific Balance Confidence scale [11], (5) the Freezing of Gait (FOG) questionnaire [12], (6) one-leg stance (OLS) test [13], (7) TUG test [14], and (8) the 6-minute walk test [15].
Patients in the trial were 30 years or older and had idiopathic PD with stable motor function; a score of 5 or greater on the Geriatric Depression Scale score; a score of 2 or greater on part I, question 3 (depression) of the Unified Parkinson's Disease Rating Scale (UPDRS); and a score of 24 or greater on the Mini-Mental State Examination, Dr.
In three trials, statistically significant improvements in the combined scores on the Unified Parkinson's Disease Rating Scale (UPDRS) were observed in early stage PD patients receiving Neupro([R]) compared with patients receiving placebo.
The Hamilton Depression Scale, Standardized Mini-Mental State Examination (SMMSE), UKU Side Effect Rating Scale and the Unified Parkinson's Disease Rating Scale (UPDRS) were applied.

Full browser ?